BridgeMD
New treatment option for Anaphylactic Reaction
Official title Steroid Use in Treatment of Allergic Reactions to Food
ClinicalTrials.gov ID: NCT07341776
What this study is testing
What is Antihistamines?
Antihistamines is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for anaphylactic reaction.
Also referred to as Dimetindene maleate, Levocetirizine.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- In this study, the investigators want to find out whether a specific medication commonly used for severe allergic reactions is really necessary. When children have allergic reactions to foods, they are often given medications to relieve the symptoms.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 18
You may be able to join if
- suspected or confirmed IgE-mediated food allergy
You likely can't join if
- Non-IgE mediated food allergies
- Non-food allergies
- Age outside the specified range
- Contraindications for an oral food challenge or oral steroid use within one week before the challenge.
The study team makes the final eligibility decision.
Where it's taking place
- Basel, Basel, Switzerland
- Zurich, Canton of Zurich, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 months to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Basel, Basel, Switzerland; Zurich, Canton of Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.